Remove 2021 Remove Compounding Remove Omnicell
article thumbnail

Summer 2021 – Transforming Pharmacy Through Innovation and Superior Customer Experience

Omnicell

Ken Osborn Senior Director, Product Marketing, Omnicell As medication management continues to be one of the top challenges of healthcare today, Omnicell’s commitment to delivering the innovation to navigate and streamline the complexities of the pharmacy care delivery model is stronger than ever.

article thumbnail

Driving Pharmacy Value Through Robotics and Connected Technology

Omnicell

Dennis Wright, Senior Director, Product Marketing, Omnicell As health systems navigate escalating staff shortages and increasingly complex drug therapies, the need for a high-performing pharmacy has never been greater. billion in 2021 and is anticipated to increase another 6 percent this year.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Reducing Drug Spend with IV Robotic Services

Omnicell

Director, Central Pharmacy Product Marketing, Omnicell IV automation technology combined with robust expert services is a game-changer for reducing drug spend while enhancing patient safety. Sterile compounding is also one of the costliest functions in pharmacy operations. Insourcing IV compounding services at Moses H.

article thumbnail

Driving Value Through Technology-as-a-Service

Omnicell

Dennis Wright Senior Director, Central Pharmacy Product Marketing, Omnicell As one of the early adopters of the vision of Autonomous Pharmacy , Texas Children's Hospital in Houston saw the opportunity for connected automation, intelligent data, and technology-enabled services to drive radical change in their medication management strategy.

article thumbnail

Overcoming Challenges Faced by Women in Healthcare Leadership

Omnicell

Denise Cox SVP, Chief Customer Officer, North America, Omnicell Women currently hold more than 75% of all healthcare jobs in the United States, versus just 8% in the 1960s. Implications for women of color are even worse, with only 5% of C-suite positions held by minority women.